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doi:10.1Objectives: We have previously shown in a model of pressure-overload hypertrophy that there is increased
cardiomyocyte apoptosis during the transition from peak hypertrophy to ventricular decompensation. Electron
transport chain dysfunction is believed to play a role in this process through the production of excessive reactive
oxygen species. In this study we sought to determine electron transport chain function in pressure-overload
hypertrophy and the role of oxidative stress in myocyte apoptosis.
Methods and Results: Neonatal rabbits underwent thoracic aortic banding at 10 days of age. Compensated hy-
pertrophy (4 weeks of age), decompensated hypertrophy (6 weeks of age), and age-matched controls (n¼ 4–8 per
group) as identified by serial echocardiography were studied. Electron transport chain complex activities were
determined by spectophotometry in isolated mitochondria. Complex I was significantly decreased (P ¼ .005)
at 4 weeks and further decreased at 6 weeks (P¼ .001). Complex II was significantly decreased at both time points
(4 weeks, P ¼ .003; 6 weeks, P ¼ .009). However, hyddrogen peroxide production, measured in isolated
mitochondria by fluorescence spectroscopy, was significantly decreased at 4 weeks of age in banded animals
compared with controls (P¼ .038), and mitochondrial DNA oxidative damage (measurement of 8- hydroxydeox-
yguanosine by enzyme-linked immunosorbent assay) was also significantly decreased at 4 weeks of age (P ¼
.031). Mitochondrial activated apoptosis was determined by Bax/Bcl-2 ratios (immunoblotting). Bax/Bcl-2 levels
were significantly increased in banded animals at 6 weeks.
Conclusions: In pressure-overload hypertrophy, the transition from compensated left ventricular hypertrophy to
failure and cardiomyocyte apoptosis is preceded by mitochondrial complex I and II dysfunction followed by
an increase in Bax/Bcl-2 ratios. The mechanism of apoptosis initiation is independent of increased oxidative
stress. (J Thorac Cardiovasc Surg 2010;139:1609-17)/B
SPressure-overload hypertrophy is the ventricular response to
chronically increased systolic stress in an attempt to normal-
ize wall stress and maintain contractility. Left ventricular
hypertrophy (LVH) is a risk factor for sudden death and pro-
gression to decompensated hypertrophy or heart failure and
its associated morbidity and mortality.1 Cardiomyocyte loss
through apoptosis is believed to play a role in the transition
from compensated LVH to decompensated LVH. We have
previously shown in a model of pressure-overload
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Tthrough apoptosis during the transition from peak hypertro-
phy to ventricular decompensation and dilation.2,3 No clear
mechanism has been identified, but mitochondria present an
attractive target for investigation because of their gatekeeper
role in apoptosis, as well as mounting evidence for electron
transport chain (ETC) dysfunction in various models of heart
failure.
Oxidative phosphorylation occurs via the ETC located on
the inner mitochondrial membrane. The ETC is composed of
four electron transport protein complexes and the adenosine
triphosphate (ATP) synthase that harnesses the proton
motive force to generate ATP. Mitochondria isolated from
failing myocardium have shown impaired capacity for respi-
ration, various defects in ETC complexes, and decreased
oxidative phosphorylation.4,5
A by-product of oxidative phosphorylation is the genera-
tion of reactive oxygen species (ROS). The single electron
reduction of molecular oxygen at various sites in the ETC
results in superoxide formation.6,7 Approximately 2% of
all oxygen consumed in oxidative phosphorylation results
in ROS.8 The superoxide anion generated at the ETC com-
plexes is converted to hydrogen peroxide (H2O2) by the
enzyme manganese superoxide dismutase located in thediovascular Surgery c Volume 139, Number 6 1609
Abbreviations and Acronyms
ATP ¼ adenosine triphosphate
BSA ¼ bovine serum albumin
ETC ¼ electron transport chain
HIF-1a ¼ hypoxia-inducible factor-1a
H2O2 ¼ hydrogen peroxide
KCN ¼ potassium cyanide
LV ¼ left ventricle (ventricular)
LVH ¼ left ventricular hypertrophy
8-OHdG ¼ hydroxydeoxyguanosine
ROS ¼ reactive oxygen species
TUNEL ¼ terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling




Smitochondrial matrix. H2O2 can be further detoxified to H2O
by other endogenous scavenging mechanisms such as
catalase and glutathione peroxidase. There is evidence
that low concentrations of superoxide can function ‘‘physi-
ologically’’ as an intracellular messenger in various redox-
sensitive signaling pathways including hypoxia-inducible
factor-1a (HIF-1a) and phosphatidylinositol-3 kinase/
Akt.9,10 Overproduction of ROS and/or inadequate endoge-
nous scavenging mechanisms can result in mitochondrial
and cellular damage, ultimately leading to apoptosis.11
In ischemia–reperfusion injury, as well as in models of
acute myocardial infarction, mitochondrial dysfunction
leads to increased ROS generation and resultant peroxida-
tion of lipids, proteins, and DNA.12 Mitochondrial peroxida-
tive damage results in release of proapoptotic factors and
initiation of apoptosis. However, in the pressure-loaded ven-
tricle, the relationship and possible mechanism between
mitochondrial dysfunction and apoptosis remain unclear.
We hypothesize that the ETC impairment is the cause of mi-
tochondrial dysfunction in hypertrophied myocardium and
subsequent myocyte apoptosis. In this study, we sought to
also determine whether ROS production plays a role in the
mechanism of apoptosis.METHODS
LVH Model
Pressure-overload hypertrophy was achieved by placing a silk ligature
around the descending thoracic aorta of 10 day-old New ZealandWhite rab-
bits (Millbrook Farms, Amherst, Mass). The morphologic performance
(heart weight and heart weight/body weight ratios) and the echocardio-
graphic performance of this model over time have been previously
described and validated inmore detail by our group.2,13,14 Implanting a fixed
constriction in an immature animal and allowing it to grow induced
pressure-overload hypertrophy by 3 to 4 weeks of age in this model. The
progression of LVH was determined by weekly transthoracic echocardiog-
raphy. During these procedures, the animals remained unsedated to avoid
the influences of anesthetics on the results. Transthoracic echocardiography
was used to measure left ventricular (LV) wall thickness and cavity volume
as previously described.13,15 The development of hypertrophy and progres-1610 The Journal of Thoracic and Cardiovascular Sursion to failure were documented by LV mass/volume ratios as previously
described.14 As a measure of cardiac performance, shortening fraction
was determined with this formula: (diastolic diameter  systolic diame-
ter)/diastolic diameter; it is expressed as a percentage.
Animals (n ¼ 4–8 per group of banded and age-matched controls) were
humanely killed with anesthetic overdose (ketamine/xylazine) and hearts
were excised and placed on a Langendorff perfusion apparatus. After perfu-
sion with Krebs–Henseleit solution for 5minutes to wash out residual blood,
the LV was frozen in liquid nitrogen and stored at80C for future use.
Isolation of Mitochondria
Mitochondria were isolated from LV samples as previously described.16
In brief, frozen LV samples were pulverized in liquid nitrogen and sus-
pended in isolation media containing 300 mmol/L sucrose, 10 mmol/L
Kþ–HEPES buffer, pH 7.2, and 1 mmol/L Kþ–ethyleneglutaminetetraacetic
acid, pH 8.0. Samples were homogenized with glass grinding vessel for ap-
proximately 30 seconds. Nagarse (0.2 mg/mL) was added to the homoge-
nate, which was incubated on ice for 10 minutes and then centrifuged for
5 minutes at 750g at 4C. The supernatant was saved and 1 mg/mL bovine
serum albumin (BSA) was added. The supernatant was then recentrifuged
for 4 minutes at 750g at 4C, and the pellet was discarded. The resulting
supernatant was then centrifuged at 9000g for 10 minutes at 4C. The mito-
chondrial pellet was then twice resuspended in ice-cold isolation media con-
taining 1 mg/mL BSA and recentrifuged at 9000g at 4C. The final pellet
was suspended in 0.5 to 1 mL of isolation media (no BSA). Mitochondrial
protein concentrations were determined by the bicinchoninic acid method.
Immunoblotting
Protein levels of representative subunits of complexes I and II, Bax, and
Bcl2 were determined by immunoblotting. The total tissue protein extracts
were separated by gel electrophoresis with sodium dodecylsulfate–poly-
acrylamide gel electrophoresis gels. Equal protein loading was confirmed
by Coomassie blue staining of the gels. Proteins were electrophoretically
transferred to nitrocellulose membranes, incubated in 5% nonfat dry milk
in TBST (10 mmol/L Tris HCl pH 7.4, 100 mmol/L NaCl, and 0.1% Tween
20) for 1 hour and then incubated overnight with primary antibody against
complex I (iron-sulfur protein 3 and ND6 protein from Invitrogen Corpora-
tion, Carlsbad, Calif), complex II (succinate dehydrogenase complex, sub-
unit A [SDHA] flavoprotein from Invitrogen), Bax, and Bcl-2 (Millipore,
Billerica, Mass). This was followed by incubation with horseradish perox-
idase–conjugated secondary antibody with primary antibody at a dilution of
1:1000. The bound antibody was detected by enhanced chemiluminescence
method according to the manufacturer’s protocol (GE Healthcare Life Sci-
ences, Waukesha, Wis). After exposure on film, quantitative protein analy-
sis was conducted by laser densitometry. Data are expressed as arbitrary
densitometry units.ETC Activity
Mitochondrial ETC complex I, II, and III activities were measured by
spectophotometry in isolated mitochondria as previously described.17 For
complex I, mitochondria (20 mg/mL) underwent three cycles of freeze-thaw-
ing in hypotonic media (25 mmol/L potassium phosphate and 5 mmol/L
MgCl2) and were then added to buffer containing 25 mmol/L KH2PO4, 5
mmol/L MgCl2, 2 mmol/L potassium cyanide (KCN), 2.5 mg/mL BSA, 2
mg/mL antimycin A, and 0.13 mmol/L reduced nicotinamide adenine dinu-
cleotide. The decrease in absorbance resulting from the oxidation of reduced
nicotinamide adenine dinucleotide was measured at 345 nm. Rotenone (2
mg/mL) was added and rotenone sensitive activity was recorded. Complex
II activity was measured in mitochondria after three cycles of freeze-thaw-
ing in hypotonic media (25 mmol/L potassium phosphate and 5 mmol/L
MgCl2) and then preincubated in buffer containing 25 mmol/L KH2PO4,
5 mmol/LMgCl2, and 20mmol/L succinate for 10minutes at 30
C followed
by addition of antimycin A (2 mg/mL), rotenone (2 mg/mL), KCN (2 mmol/gery c June 2010
Griffiths et al Evolving Technology/Basic ScienceL), and dichlorophenolindophenol (50 mmol/L). The reaction was catalyzed
by addition of 65 mmol/L ubiquinone, and the reduction of dichloropheno-
lindophenol was measured at 600 nm for 2 to 3 minutes. Complex III activ-
ity was determined by measuring the increasing reduction of cytochrome c
at 550 nm. Mitochondria were added to buffer containing 25 mmol/L
KH2PO4, 5 mmol/L MgCl2, 2 mmol/L KCN, 2 mg/mL rotenone, and 15
mmol/L cytochrome c followed by the addition of ubiquinol (35 mmol/L).
Complex IV activity was measured by the cytochrome c oxidase kit (CY-
TOCOX1) from Sigma-Aldrich (St Louis, Mo).Determination of ROS Production
ROS production by mitochondria was determined by measuring the gen-
eration of H2O2 using fluorescence spectroscopy with Amplex Red Hydro-
gen Peroxide/Peroxidase Assay from Invitrogen in isolated mitochondria
using 5 mmol/L glutamate and 5 mmol/L malate without the addition of
adenosine diphosphate as the substrate for respiration. Mitochondria iso-
lated from frozen tissue had 17% to 26% lower activity than mitochondria
from fresh tissue, but the rate of the reaction was within an acceptable range.
ROS-mediated DNA damage was assessed by measuring 8-hydroxydeoxy-
guanosine (8-OHdG) in both nuclear and mitochondrial DNA by specific
enzyme-linked immunosorbent assay (8-OHdG Check Ultrasensitive
ELISA; BioVendor R&D, Modrice, Czech Republic). Isolation of nuclear
DNA was performed by digestion with proteinase K and then extracted in
chloroform/isoamyl alcohol and phenol as previously described.18 Mito-
chondrial DNA was obtained by treating isolated mitochondria with pro-
teinase K (10 mg/mL) in sodium dodecylsulfate (54 mg/mL) followed by




SDetermination of Apoptosis by TUNEL
Cardiolmyocyte apoptosis was quantified by terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) staining. LV mus-
cle paraffin sections from the midsection of the heart were deparaffinized
and then rehydrated with xylene and graded alcohol series. The sections
were stained with the FragEL DNA fragmentation detection kit (EMD; Bio-
sciences Inc, San Diego, Calif) per the manufacturer’s instructions. In brief,
the sections were incubated with terminal deoxynucleotidyl transferase and
fluorescein-labeled dUTP. So that the cardiomyocytes could be identified,
sections were incubated with mouse desmin monoclonal antibody
(Sigma-Aldrich), followed by incubation with a secondary antimouse
immunoreagent conjugated to the red-fluorescent Alexa-594 fluorophore
at a concentration of 1:200 (Molecular Probes, Eugene Ore). Finally, so
that all nuclei (nonapoptotic and apoptotic) could be identified, sections
were stained with blue fluorescent DAPI nucleic acid stain (Molecular
Probes). Coverslips were applied to the sections with fluorescent mounting
medium (Dako Corporation, Carpinteria, Calif). Slides were visualized
using an Axiovert 35 Microscope with a Nikon 103 objective, NA ¼ 10
3 /0.25. Cardiomyocyte nuclei were determined by automatic counting
with the computer software/image analyzer using the MetaMorph Imaging
System software (Universal Imaging Corporation, West Chester, Pa).
Apoptotic nuclei were identified manually to determine that only apoptotic
cardiomyocyte nuclei were included. Data are expressed as apoptotic nuclei
per 1000 nuclei.Animal Care
All animals received humane care in compliance with the ‘‘Principles of
Laboratory Animal Care’’ formulated by the National Society for Medical
Research and the ‘‘Guide for the Care and Use of Laboratory Animals’’ pre-
pared by the National Academy of Sciences and published by the National
Institutes of Health (NIH Publication No. 86-23, revised 1996). The proto-
col was reviewed and approved by the Institutional Animal Care and Use
Committee at Children’s Hospital Boston.The Journal of Thoracic and CarStatistical Analysis
Data were analyzed with SPSS software package (version 15.0; SPSS
Inc, Chicago, Ill) and are reported as mean  standard error of the mean.
A 2-tailed unpaired Student t test was used for comparison between groups:
at 4 weeks (control versus banded) and at 6 weeks (control versus banded),
if normality was passed, analysis of variance was used for analysis of the
TUNEL staining where 3 groups were analyzed (control, 4 weeks banded,
and 6 weeks banded.
Statement of Responsibility
The authors had full access to the data and take full responsibility for
their integrity. All authors have read and agree to the manuscript as written.RESULTS
LVH Model
After aortic banding, the animals had peak LVH at 4 to 5
weeks of age with a significantly increased mass/volume
ratio (Figure 1). Cardiac performance, as measured by frac-
tional shortening, was preserved at 4 weeks of age. By 6
weeks of age the mass/volume ratio had decreased signifi-
cantly, indicating ventricular dilation, and was accompanied
by contractile dysfunction evidenced by a decreased
fractional shortening. These animals had no clinical signs
of failure such as ascites or pleural effusions. Given these
findings, animals were then studied at 4 weeks of age to eval-
uate compensated hypertrophy and at 6 weeks of age to eval-
uate decompensated hypertrophy.ETC Complex Activity and Protein Expression
To identify the defect in oxidative phosphoryation, we
measured the ETC complex activities by spectrophotometry
in isolated mitochondria at 4 and 6 weeks of age. Complex I
(Figure 2, A) showed significant impairment in the banded
animals in hypertrophy. Complex II (Figure 2, B) also
showed significant impairment. There was further impair-
ment of both complexes with ventricular decompensation
at 6 weeks of age. Complex III activity (Figure 2, C) was
unchanged in both hypertrophy and decompensated hyper-
trophy. Complex IV activity (Figure 2, D) was slightly
increased in the banded animals during LVH but normalized
to control levels with ventricular dilation.
To determine whether the decrease in complex I and II ac-
tivities was attributable to a decrease in complex subunit
expression, we measured the protein levels of representative
subunits by immunoblotting. Figure 3, A, shows that the
nuclear-encoded, 30-kDa iron-sulfur protein 3 subunit of
complex I was unchanged versus controls at both 4 and 6
weeks of age. Figure 3, B, shows the 20-kDa, ND6 subunit
of complex I, which is encoded by mitochondrial DNA, was
unchanged at both time points as well. Figure 3, C, shows
that the 70-kDa flavoprotein subunit of complex II, which
is the only ETC complex entirely encoded by nuclear
DNA, was unchanged in both LVH and decompensated
LVH.diovascular Surgery c Volume 139, Number 6 1611
FIGURE 1. Transthoracic echocardiography showing development of LVH and later decompensation. A, Increase in mass/volume (M/V) ratio indicating
that peak hypertrophy in the banded animals occurred at 4 to 5 weeks of age followed by ventricular dilatation at 6 weeks of age, evidenced by a decrease in
M/V ratio. B, Contractile performance was assessed by fractional shortening (FS). The FS was preserved during hypertrophy at 4 weeks of age and decreased
as the ventricle dilated at 6 weeks (n¼ 6–11; *P .05). C, There was no significant difference in animal body weights. Banded animals at 6 weeks of age had
no clinical signs of heart failure such as ascites or pleural effusions.




SDetermination of ROS Generation and Peroxidative
Damage
To determine whether complex I and II dysfunction
results in altered ROS generation, we measured H2O2FIGURE 2. ETC complex activities measured by spectophotometry in isolated m
(6 weeks) LVmyocardium. Complex I (A) and complex II (B) activities were sign
weeks of age. C, Complex III activity was unchanged. D, Complex IV activity w
(n ¼ 4; *P< .005, yP ¼ .009, zP ¼ .03).
1612 The Journal of Thoracic and Cardiovascular Surproduction in isolated mitochondria using 5-mmol/L gluta-
mate and 5-mmol/L malate as substrates for oxidative phos-
phorylation. Figure 4 shows that ROS production was
significantly decreased in LVH at 4 weeks of age anditochondria from hypertrophied (4 weeks) and decompensated hypertrophy
ificantly decreased at 4 weeks of age and further decreased significantly at 6
as significantly increased at 4 weeks of age but normalizes at 6 weeks of age
gery c June 2010
FIGURE 3. Western blot analysis of ETC complex subunit protein levels at 4 weeks and 6 weeks of age. Representative blots are shown. Nuclear encoded,
30-kDa iron-sulfur protein 3 (A) and the mitochondrial-encoded 20-kDa, ND6 subunits (B) of complex I are unchanged at both time points. C, The protein
level of the complex II 70-kDa flavoprotein is unchanged change as well. Representative immunoblots are shown and bar graphs depict cumulative data,
which are expressed are as means  SEM (n ¼ 4).




Sremained decreased in decompensated hypertrophy at 6
weeks of age. To confirm the decrease in ROS generation,
we measured 8-OHdG, which is a marker for free radical–
mediated DNA damage. There was no significant difference
in the amount of oxidative damage in nuclear DNA
(Figure 5, A). However, mitochondrial DNA contained sig-
nificantly less oxidative damage in the hypertrophied LV at
4 weeks of age than controls (Figure 5, B). At 6 weeks of
age, the amount of 8-OHdG was decreased but not signifi-
cantly in decompensated LV. These results are consistent
with the findings of decreased H2O2 production in isolated
mitochondria from hypertrophied LV.Activation of Apoptosis
The presence of cardiomyocyte apoptosis was determined
by TUNEL staining (Figure 5). There was a nonsignificantThe Journal of Thoracic and Carincrease in cardiomyocyte apoptosis at 4 weeks of age com-
pared with controls and a significant increase in banded
animals at 6 weeks of age compared with controls. To inves-
tigate whether the mitochondrial dysfunction contributed to
cardiomyocyte loss through activation of the intrinsic mito-
chondrial apoptotic pathway, we measured the proapoptotic
and antiapoptotic proteins Bax and Bcl-2. In the decompen-
sated LV at 6 weeks of age, there was a significant increase
in the amount of Bax present (see Figure 6, A) and also in the
ratio of Bax/Bcl-2 (Figure 6,B), which is indicative of a proa-
poptotic state of the mitochondria that can lead to activation
of the mitochondrial apoptosis pathway.DISCUSSION
The major findings of the present study are as follows: (1)
ETC dysfunction, specifically of complexes I and II, occursdiovascular Surgery c Volume 139, Number 6 1613
FIGURE 4. Determination of ROS generation and oxidative damage. Production of H2O2 was determined by fluorescence spectroscopy using the Amplex
Red reaction in isolated mitochondria. A, Mitochondria at 4 weeks of age (hypertrophy) showed significantly decreased H2O2 production. B, Mitochondria at
6 weeks of age (decompenated hypertrophy) show decreased, but not significantly, production of H2O2. 8-OHdG, as a marker for oxidative DNA damage, was
measured in digested nuclear and mitochondrial DNA. There was no difference in 8-OHdG levels in nuclear DNA (C) at either time point. In mitochondrial
DNA (D), 8-OHdG levels were significantly decreased at 4 weeks of age (Data are expressed as means  SEM; n ¼ 4–6; *P  .05).




Sin early hypertrophy and worsens with ventricular decom-
pensation; (2) there is no change in protein content of com-
plex I and II subunits; (3) ETC dysfunction is associated
with decreased ROS generation; and (4) the mitochondrial
dysfunction is associated with the activation of the mito-
chondrial apoptosis pathway, as indicated by Bax/Bcl-2 ra-
tios. Collectively, these findings implicate ETC dysfunction
as a potential cause of cardiomyocyte loss through apoptosis
but through means other than excessive ROS production.FIGURE 5. Western blot analysis of Bax and Bcl-2 protein levels at 6
weeks of age when cardiomyocyte apoptosis is known to be significantly in-
creased. A, Significantly increased Bax protein levels in banded animals. B,
Significantly increased Bax/Bcl-2 ratio. Representative immunoblots are
shown and bar graphs depict cumulative data, which are expressed are as
means  SEM (n ¼ 4; *P  .05).
1614 The Journal of Thoracic and Cardiovascular SurOur findings in a model of a pressure-loaded ventricle
show that complex I and II dysfunction precedes the onset
of contractile dysfunction and ventricular dilatation. This in-
dicates that initially the impairment is not sufficient to inhibit
the production of adequate amounts of ATP for basal con-
tractile function. The impairment could explain the reported
finding of impaired ATP production at high work states in
hypertrophied myocardium.19 Worsening complex dysfunc-
tion coincides with the onset of ventricular dilation and
worsening contractile function. These data are consistent
with the decreased amounts of ATP in failing myocardium
reported in multiple models of heart failure.20 It must be
noted that the impairment of ETC complex activities causing
decreased oxidative phosphorylation has not been firmly es-
tablished in heart failure and requires further investigation.
There was a significant decrease in activity in both com-
plexes I and II in control animals from 4 weeks to 6 weeks
of age. Because little is known about mitochondrial changes
in the neonatal period, the use of a developing animal may
confound the results seen in the control group, that is,
decreases in activity of complexes I and II may occur with
maturation of the animal. Despite the decreases in the activ-
ities of complexes I and II in the control animals, banded
animals had significantly worse complex activities.
The decrease in complex activity is not attributable to
a decrease in complex subunit proteins, as we found that rep-
resentative subunits from complexes I and II were not
decreased. Complex I is composed of 45 proteins, 7 of which
are encoded by the mitochondrial genome. Complex II is thegery c June 2010
FIGURE 6. Summarized results of TUNEL staining for cardiomyocyte apoptosis at 4 weeks and 6 weeks of age in aortic banded and control animals. There
was a nonsignificant increase in cardiomyocyte apoptosis at 4 weeks of age compared with controls and a significant increase in banded animals at 6 weeks of
age compared with controls. Results are expressed as means  SD (n ¼ 3) of TUNEL-positive cardiomyocyte nuclei per 1000 nuclei. *P ¼ .025.




Sonly complex entirely encoded by nuclear DNA and is com-
posed of 7 subunits. The subunits we elected to quantify
have been reported as key subunits of each impaired com-
plex. The 30-kDA, nuclear-encoded, iron-sulfur protein 3
subunit and mitochondrial-encoded ND6 subunit of com-
plex I are both a part of the core electron transfer apparatus
that is most likely to affect complex function if decreased in
quantity.21,22 The succinate dehydrogenase complex subunit
A of complex II is a 70-kDa flavoprotein involved in the
electron transfer process.23 Other possibilities exist that
could explain the decreased function. Improper assembly
of complexes by their constituent subunits or even posttrans-
lation modifications could lead to impaired functioning as
well.24 Differential expression of ETC subunit isoforms
that alters their activities has been described in yeast under
hypoxic conditions, raising the possibility that isoform
switching may occur as a result of the metabolic stress
involved in the chronically pressure-loaded ventricle.25
The mechanism of impairment of ETC complex activity is
not well understood. Recent studies have focused on possi-
ble posttranslational modifications that might function to
regulate oxidative phosphorylation. Possible mechanisms
include reversible processes such as phosphorylation, acety-
lation, palmytoylation, and glycosylation, and/or irrevers-
ible processes involving cleavage or degradation of the
subunits. Many of these posttranslational modifications
have been identified in complex I but remain under
investigation.26,27
We found that the impairment of complex I and II activity
resulted in decreased production of H2O2 in isolated mito-
chondria from hypertrophied myocardium compared with
age-matched controls. The decreased production of mito-
chondrial ROS was confirmed by the decreased amounts
of 8-OHdG, a marker of ROS-induced DNA damage inThe Journal of Thoracic and Carmitochondrial DNA. Because of its proximity to the ETC,
the lack of negatively charged histone proteins, and the
less efficient DNA repair mechanisms, mitochondrial
DNA is particularly susceptible to ROS-mediated damage.
Complex I and II impairment decreases production of
ROS by limiting the flux through the ETC. Inasmuch as
ROS is a by-product of oxidative phosphorylation, a de-
crease in oxidative phosphorylation results in a proportional
decrease in ROS generation.
The lack of nuclear DNA damage in hypertrophy and
decompensated hypertrophy indicates that the ROS gener-
ated from all sources are sufficiently detoxified, preventing
nuclear DNA damage. This is an important finding because
other sources of ROS are reportedly active in the hypertro-
phied LV. The cytosolic reduced nicotinamide adenine dinu-
cleotide phosphate oxidase enzyme has been found to play
a role in LVH through ROS-dependent activation of mito-
gen-activated protein kinase pathways in angiotensin II
and endothelin-induced models of hypertrophy.7,28 Elevated
levels of ROS generated in a reduced nicotinamide adenine
dinucleotide phosphate oxidase may be sufficient to induce
hypertrophic signaling but insufficient to incur oxidative
damage.
Our findings of decreased oxidative stress in pressure-
overload hypertrophy are in contrast to the documented
role ROS play in heart failure models from ischemia–reper-
fusion or acute myocardial infarction. In our model, the
aortic band is placed in a nonconstricting fashion such that
the pressure load gradually develops as do the structural
and metabolic changes seen in LVH. This contrasts signifi-
cantly with the models of ischemia–reperfusion and acute
myocardial infarction, where a relatively healthy ventricle
sustains an acute insult that leads to rapid development of
multiple metabolic and structural abnormalities includingdiovascular Surgery c Volume 139, Number 6 1615




Scardiomyocyte apoptosis. However, the mechanism by
which apoptosis is induced likely varies between the differ-
ent models. Elevated ROS induce lipid and protein peroxida-
tion in the inner mitochondrium, which in sufficient quantity
can promote release of cytochrome c into the cytosol and ac-
tivate apoptosis. Therefore, efforts in these models aim to
decrease ROS generation or peroxidative damage through
free radical scavenging.12
Our findings in a pressure-loaded ventricle show ETC im-
pairment precedes the onset of cardiomyocyte apoptosis,
which was found to be significantly increased at 6 weeks
of age.3 We document the activation of the mitochondrial
apoptotic pathway through an increase in the Bax/Bcl-2 ra-
tio. Homodimerazation of Bax and incorporation into the
outer mitochondrial membranes (which is prevented by
Bcl-2) results in loss of mitochondrial membrane potential
and leakage of proapoptotic proteins into the cytosol and ul-
timately activating downstream effector caspases. We dem-
onstrated increased levels of Bax in decompensated
hypertrophy hearts as well as an increased Bax/Bcl-2 ratio
independent of increased oxidative stress. The increased
Bax/Bcl-2 ratio at 6 weeks of age corresponds to the time
when cardiomyocyte apoptosis is significantly increased in
our model.3 The mechanism by which Bax levels are in-
creased is not clear. However, increased oxidative stress
does not appear to play a role. An important contributor
may be the lack of appropriate signaling through the HIF-
1a pathway, which is a key regulator of cell survival.29,30
We31 have previously found in our model that HIF-1a fails
to translocate into the nucleus in hypertrophied hearts when
subjected to hypoxia, indicating a defect in HIF-1a signal-
ing. Key to the nuclear translocation of HIF-1a is stabiliza-
tion by ROS, preventing its degradation. If decreased ROS
production limits the stabilization and subsequent transloca-
tion of HIF-1a, then the compensatory response would be
inadequate to mitigate the effects of hypoxia or cellular
stress.
ETC dysfunction with a resultant decrease in ROS
production is a key finding in the pathogenesis of LVH
and its progression to failure. The magnitude of its contribu-
tion to cardiomyocyte apoptosis, either through impaired
oxidative phosphorylation and energy production or through
altered ROS metabolism, requires further study. To better
define the cause of ETC complex dysfunction, it will be
necessary to take a proteomics approach to assess complex
protein composition and posttranslational modifications.
Understanding the specific mechanisms of the ETC dysfunc-
tion is essential to design appropriate interventions to alter
the progression of hypertrophy and development of cardiac
failure.Special thanks to DrMoritzWyler von Ballmoos and Dr Huamei
He for their technical assistance.1616 The Journal of Thoracic and Cardiovascular SurReferences
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